BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15105131)

  • 1. Dose-dependent pharmacokinetics of itraconazole after intravenous or oral administration to rats: intestinal first-pass effect.
    Shin JH; Choi KY; Kim YC; Lee MG
    Antimicrob Agents Chemother; 2004 May; 48(5):1756-62. PubMed ID: 15105131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of DA-8159, a new erectogenic, after intravenous and oral administration to rats: hepatic and intestinal first-pass effects.
    Shim HJ; Kim YC; Park KJ; Kim DS; Kwon JW; Kim WB; Lee MG
    J Pharm Sci; 2003 Nov; 92(11):2185-95. PubMed ID: 14603504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of ipriflavone, an isoflavone derivative, after intravenous and oral administration to rats hepatic and intestinal first-pass effects.
    Kim SH; Lee MG
    Life Sci; 2002 Feb; 70(11):1299-315. PubMed ID: 11883708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-independent pharmacokinetics of metformin in rats: Hepatic and gastrointestinal first-pass effects.
    Choi YH; Kim SG; Lee MG
    J Pharm Sci; 2006 Nov; 95(11):2543-52. PubMed ID: 16937336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic and intestinal first-pass effects of oltipraz in rats.
    Bae SK; Kim JW; Kim YH; Kim YG; Kim SG; Lee MG
    Biopharm Drug Dispos; 2005 May; 26(4):129-34. PubMed ID: 15744718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-independent pharmacokinetics of a candidate for diabetic neuropathy, SR-4668, after intravenous and oral administration to rats: Intestinal first-pass effect.
    Kim EJ; Bae SK; Kim HJ; Kim YG; Kim SO; Lee DH; Lim H; Lee MG
    J Pharm Sci; 2003 May; 92(5):1112-24. PubMed ID: 12712431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-independent pharmacokinetics of a new neuroprotective agent for ischemia-reperfusion damage, KR-31543, after intravenous and oral administration to rats: hepatic and intestinal first-pass effects.
    Lee MH; Bae SK; Kim EJ; Kim YG; Kim SO; Lee DH; Lim H; Yoo SE; Lee MG
    J Pharm Sci; 2003 Jan; 92(1):190-201. PubMed ID: 12486695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of a chemoprotective agent, 2-(allylthio)pyrazine, after intravenous and oral administration to rats: hepatic and gastric first-pass effects.
    Han KS; Lee MG
    Drug Metab Dispos; 1999 Feb; 27(2):221-6. PubMed ID: 9929506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of sildenafil after intravenous and oral administration in rats: hepatic and intestinal first-pass effects.
    Shin HS; Bae SK; Lee MG
    Int J Pharm; 2006 Aug; 320(1-2):64-70. PubMed ID: 16730145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal first-pass effect of YJA-20379-8, a new reversible proton pump inhibitor, in rats.
    Kim J; Kim EJ; Han KS; Chang MS; Lee MG
    J Pharm Pharmacol; 1999 Sep; 51(9):1031-6. PubMed ID: 10528986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of DA-7867, a new oxazolidinone, after intravenous or oral administration to rats: intestinal first-pass effect.
    Bae SK; Chung WS; Kim EJ; Rhee JK; Kwon JW; Kim WB; Lee MG
    Antimicrob Agents Chemother; 2004 Feb; 48(2):659-62. PubMed ID: 14742232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-independent pharmacokinetics of a new reversible proton pump inhibitor, KR-60436, after intravenous and oral administration to rats: gastrointestinal first-pass effect.
    Yu SY; Bae SK; Kim EJ; Kim YG; Kim SO; Lee DH; Lim H; Lee MG
    J Pharm Sci; 2003 Aug; 92(8):1592-603. PubMed ID: 12884246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-dependent pharmacokinetics of a new reversible proton pump inhibitor, DBM-819, after intravenous and oral administration to rats: hepatic first-pass effect.
    Kim EJ; Kim SO; Lee DH; Lim H; Lee MG
    Biopharm Drug Dispos; 2001 Apr; 22(3):119-28. PubMed ID: 11745914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-dependent pharmacokinetics of telithromycin after intravenous and oral administration to rats: contribution of intestinal first-pass effect to low bioavailability.
    Lee JH; Lee MG
    J Pharm Pharm Sci; 2007; 10(1):37-50. PubMed ID: 17498392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal first-pass effect of bumetanide in rats.
    Kim EJ; Han KS; Lee MG
    Int J Pharm; 2000 Jan; 194(2):193-9. PubMed ID: 10692643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-Dependent Pharmacokinetics of Tofacitinib in Rats: Influence of Hepatic and Intestinal First-Pass Metabolism.
    Lee JS; Kim SH
    Pharmaceutics; 2019 Jul; 11(7):. PubMed ID: 31284540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-independent pharmacokinetics of clindamycin after intravenous and oral administration to rats: contribution of gastric first-pass effect to low bioavailability.
    Yang SH; Lee MG
    Int J Pharm; 2007 Mar; 332(1-2):17-23. PubMed ID: 17157458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of a new reversible proton pump inhibitor, YH1885, after intravenous and oral administrations to rats and dogs: hepatic first-pass effect in rats.
    Han KS; Kim YG; Yoo JK; Lee JW; Lee MG
    Biopharm Drug Dispos; 1998 Nov; 19(8):493-500. PubMed ID: 9840211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absorption, first-pass metabolism, and disposition of itraconazole in rats.
    Yoo SD; Kang E; Jun H; Shin BS; Lee KC; Lee KH
    Chem Pharm Bull (Tokyo); 2000 Jun; 48(6):798-801. PubMed ID: 10866139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver and gastrointestinal first-pass effects of azosemide in rats.
    Kim J; Kim SH; Lee MG
    J Pharm Pharmacol; 1997 Sep; 49(9):878-83. PubMed ID: 9306255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.